Synthetic THC And Blood Pressure

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07231965
Phase
PHASE2/PHASE3
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Blood Pressure

Eligibility Criteria

Sex
ALL
Age
21 Years - 40 Years
Healthy Volunteers
Not accepted

Interventions

  • Dronabinol — DRUG
    Patients will take one 10 mg dose of Dronabinol.
  • Placebo — DRUG
    Patients will take one 10mg dose of a Placebo Pill.

Study Details

To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology

Key Dates

Start date
Jul 31, 2026
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT

Arms

  • Active Comparator: Dronabinol Group
    Patients taking Dronabinol first and Placebo second
  • Active Comparator: Placebo Group
    Patients taking Placebo first and Dronabinol second

Primary Outcome Measure

Blood Pressure [ Time Frame: Baseline, 30 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905-

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies